中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates

文献类型:期刊论文

作者Shi, Wei3,4,5; Li, Wanzhen2; Zhang, Jianxin2; Li, Tiehai5; Song, Yakai5; Zeng, Yue5; Dong, Qian5; Lin, Zeng5; Gong, Likun5; Fan, Shuquan1
刊名ACTA PHARMACEUTICA SINICA B
出版日期2022-05-01
卷号12期号:5页码:2417-2428
ISSN号2211-3835
关键词Site-specific ADCs ENGase LacNAc One-step assembly Potent in vivo efficacy
DOI10.1016/j.apsb.2021.12.0132211-3835
通讯作者Tang, Feng(tangfeng2013@simm.ac.cn) ; Huang, Wei(huangwei@simm.ac.cn)
英文摘要Glycosite-specific antibody???drug conjugatess (gsADCs), harnessing Asn297 N-glycan of IgG Fc as the conjugation site for drug payloads, usually require multi-step glycoengineering with two or more enzymes, which limits the substrate diversification and complicates the preparation process. Herein, we report a series of novel disaccharide-based substrates, which reprogram the IgG glycoengineering to one-step synthesis of gsADCs, catalyzed by an endo-N-acetylglucosaminidase (ENGase) of Endo-S2. IgG glycoengineering via ENGases usually has two steps: deglycosylation by wild-type (WT) ENGases and transglycosylation by mutated ENGases. But in the current method, we have found that disaccharide LacNAc oxazoline can be efficiently assembled onto IgG by WT Endo-S2 without hydrolysis of the product, which enables the one-step glycoengineering directly from native antibodies. Further studies on substrate specificity revealed that this approach has excellent tolerance on various modification of 6-Gal motif of LacNAc. Within 1 h, one-step synthesis of gsADC was achieved using the LacNAc-toxin substrates including structures free of bioorthogonal groups. These gsADCs demonstrated good homogeneity, buffer stability, in vitro and in vivo anti-tumor activity. This work presents a novel strategy using LacNAc-based substrates to reprogram the multi-step IgG glycoengineering to a one-step manner for highly efficient synthesis of gsADCs. 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
WOS关键词BETA-N-ACETYLGLUCOSAMINIDASE ; TRANSGLYCOSYLATION ACTIVITY ; CHEMOENZYMATIC SYNTHESIS ; GLYCOSYNTHASE MUTANTS ; GLYCOSYLATION ; ENDOGLYCOSIDASE ; GENERATION ; IMPROVES
资助项目National Natural Science Foundation of China (NSFC)[2187116] ; National Natural Science Foundation of China (NSFC)[82003574] ; Shanghai Municipal Science and Technology Major Project ; Shanghai Sail Program[19YF1457100] ; Special Research Assistant Program (Chinese Academy of Sciences, CAS) ; Natural Science Foundation of Shandong Province[ZR2017BC062]
WOS研究方向Pharmacology & Pharmacy
语种英语
出版者INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
WOS记录号WOS:000810964300009
源URL[http://119.78.100.183/handle/2S10ELR8/301489]  
专题中国科学院上海药物研究所
通讯作者Tang, Feng; Huang, Wei
作者单位1.Liaocheng Univ, Sch Life Sci, Liaocheng 252059, Shandong, Peoples R China
2.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210023, Peoples R China
3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China
4.Hangzhou Inst Adv Study, Sch Pharmaceut Sci & Technol, Hangzhou 310024, Peoples R China
5.Chinese Acad Sci, Shanghai Inst Mat Med, Ctr Biotherapeut Discovery Res, CAS Key Lab Receptor Res,CAS Ctr Excellence Mol C, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Shi, Wei,Li, Wanzhen,Zhang, Jianxin,et al. One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates[J]. ACTA PHARMACEUTICA SINICA B,2022,12(5):2417-2428.
APA Shi, Wei.,Li, Wanzhen.,Zhang, Jianxin.,Li, Tiehai.,Song, Yakai.,...&Huang, Wei.(2022).One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates.ACTA PHARMACEUTICA SINICA B,12(5),2417-2428.
MLA Shi, Wei,et al."One-step synthesis of site-specific antibody-drug conjugates by reprograming IgG glycoengineering with LacNAc-based substrates".ACTA PHARMACEUTICA SINICA B 12.5(2022):2417-2428.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。